Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Aaron M. Goodman(University of California San Diego), Razelle Kurzrock(Medical College of Wisconsin), Sandip Pravin Patel(University of California San Diego), Garrett M. Frampton(Tech Foundation), Shumei Kato(Center for Personalized Cancer Treatment), Vincent A. Miller(Universidad San Carlos), Gregory A. Daniels(University of California San Diego), Philip J. Stephens(United States Department of the Navy), Lyudmila Bazhenova(Memorial Sloan Kettering Cancer Center)
Cited by 2,388
Related Papers
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
|Genome Medicine|2017|3.7k
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
|Molecular Cancer Therapeutics|2015|2.3k